| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 0.00 | 0.00 | 0.00 | 72.00K | 0.00 | 0.00 |
| Gross Profit | -1.72M | -1.39M | -17.00K | 55.00K | -15.00K | -18.00K |
| EBITDA | -4.78M | -6.52M | 0.00 | -3.42M | -5.21M | 0.00 |
| Net Income | -5.08M | -6.62M | -5.27M | -3.47M | -5.21M | -5.60M |
Balance Sheet | ||||||
| Total Assets | 239.00K | 314.00K | 78.00K | 410.00K | 3.08M | 7.99M |
| Cash, Cash Equivalents and Short-Term Investments | 239.00K | 314.00K | 78.00K | 349.00K | 3.00M | 7.92M |
| Total Debt | 5.08M | 3.50M | 3.20M | 61.00K | 80.00K | 65.00K |
| Total Liabilities | 8.13M | 4.44M | 6.42M | 1.48M | 684.00K | 383.00K |
| Stockholders Equity | -7.89M | -4.13M | -6.34M | -1.07M | 2.40M | 7.61M |
Cash Flow | ||||||
| Free Cash Flow | -2.48M | -8.91M | -3.47M | -2.65M | -4.92M | 5.07M |
| Operating Cash Flow | -2.48M | -8.91M | -3.47M | -2.65M | -4.92M | 5.07M |
| Investing Cash Flow | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financing Cash Flow | 2.20M | 9.14M | 3.20M | 0.00 | 0.00 | 0.00 |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | $19.57M | 2.63 | 5.96% | ― | 6.08% | 123.07% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
61 Neutral | $19.37M | 3.30 | 28.32% | 2.37% | 10.31% | 37.72% | |
45 Neutral | $65.75M | -1.50 | -34.57% | ― | 47.63% | 48.30% | |
45 Neutral | $28.65M | ― | ― | ― | ― | ― | |
42 Neutral | $16.26M | -3.19 | 237.91% | ― | ― | 50.13% |
In January 2025, AmBase Corporation entered into a $100,000 senior promissory note with its chairman and CEO, Richard A. Bianco, providing working capital at an annual interest rate of 6.5% and maturing upon receipt of sufficient funds from any source or by January 31, 2029, with an option for Bianco to convert the loan and accrued interest into a pari passu litigation funding arrangement. The company reiterated its going-concern uncertainties and signaled that it is actively exploring a range of additional financing and litigation funding alternatives, including potential equity or debt issuance, loans, and possible sale or monetization of its interest and rights in the 111 West 57th property, while cautioning that there is no assurance it will secure such funding on acceptable terms or prevail in its related legal claims.
The most recent analyst rating on (ABCP) stock is a Sell with a $0.19 price target. To see the full list of analyst forecasts on AmBase stock, see the ABCP Stock Forecast page.
In December 2025, AmBase Corporation entered into a $300,000 senior promissory note with its chairman, president and CEO, Richard A. Bianco, who is providing the loan at 6.5% annual interest for working capital needs, with repayment due upon receipt of sufficient funds from any source (excluding certain litigation funding for the 111 West 57th proceedings) or by December 31, 2028, and with an option for Bianco to convert the note and interest into a litigation funding arrangement on equal footing with any third-party litigation funders. The company, whose auditors have raised substantial doubt about its ability to continue as a going concern, is actively evaluating additional financing options, including up to $5 million of potential litigation funding, equity or debt offerings, and possible sale or monetization of its interest or rights in the 111 West 57th property, though it cautions there is no assurance it can secure such funding on acceptable terms or prevail in its ongoing legal disputes, leaving stakeholders exposed to continued financial and legal uncertainty.
In November 2025, AmBase Corporation entered into a Senior Promissory Note with its Chairman and CEO, Richard A. Bianco, for a $100,000 loan at 6.5% interest to support working capital. The company is actively seeking additional funding to continue operations and litigation concerning the 111 West 57th Property, exploring options such as litigation funding agreements and potential sales of its interests. However, there is no assurance of securing such funding on favorable terms, and the company continues to face challenges related to its financial stability and ongoing legal proceedings.